Abstract
Demonstration and quantification of site-specific intracoronary administration of pharmacological compounds has been limited thus far to animal experimental models. Recently, a method applicable in humans has been developed. The aim of this study is to give an overview on the available methods to visualize and quantify intravascularly administered "labeled" drugs in animals and to describe the historical development of a method now applied in the clinical arena. The potential of this approach is briefly summarized.
MeSH terms
-
Aged
-
Angina, Unstable / diagnostic imaging
-
Angina, Unstable / drug therapy*
-
Angioplasty, Balloon, Coronary / instrumentation*
-
Animals
-
Anticoagulants / administration & dosage*
-
Aortic Dissection / diagnostic imaging
-
Coronary Aneurysm / diagnostic imaging
-
Coronary Aneurysm / drug therapy
-
Drug Delivery Systems / instrumentation*
-
Feasibility Studies
-
Heparin / administration & dosage*
-
Humans
-
Image Processing, Computer-Assisted
-
Male
-
Myocardial Infarction / diagnostic imaging
-
Myocardial Infarction / drug therapy*
-
Radionuclide Imaging
-
Thrombolytic Therapy / instrumentation*
-
Treatment Outcome